Delivery Order SPE2DB24D9246-SPE2DB25FGUSM
Award Date
4/21/25
Potential Completion Date
5/12/25
Potential Value
$6.9K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $6,291.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,556,217,484 units of the contraceptive implant NEXPLANON 68 MG and has a completion date of February 28, 2022. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $10,414.65, is for the delivery of 4,567,805,882 units of NEXPLANON 68 MG IMPLANTS, a contraceptive medical device. The contract has an ultimate completion date of April 21, 2025 and was awarded on March 31, 2025. DMS Pharmaceutical Group Inc. is also the holder of a $499,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a $25,728.84 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of 4,565,176,099 units of the NEXPLANON 68 MG IMPLANTS contraceptive product. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which runs through December 31, 2025. The IDC allows the DLA to issue...
The Defense Logistics Agency (DLA) awarded a $10,720.35 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,566,777,703 units of the contraceptive implant NEXPLANON 68 MG. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive range of pharmaceutical products and medical supplies for the Department of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,497.58, is for the delivery of 4,567,925,923 units of the NEXPLANON 68 MG IMPLANTS contraceptive device. The contract has an ultimate completion date of May 5, 2025 and was awarded on April 14, 2025. DMS Pharmaceutical Group Inc. also holds a larger $499,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $20,829.30, is for the delivery of 4,567,571,253 units of NEXPLANON 68 MG IMPLANTS, a contraceptive implant. The contract has an ultimate completion date of April 2, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant $499,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 4,567,979,703 units of Nexplanon 68 mg implants, a contraceptive device, with a ceiling value of $33,326.88. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows the agency to issue delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $6,248.79 contract is for the delivery of 4,567,803,233 units of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of April 21, 2025 and is not associated with any set-aside designation. DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $20,512.20 contract is for the supply of 4,561,106,462 units of the contraceptive device NEXPLANON 68 MG IMPLANTS. The contract has a performance period ending on June 20, 2023. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,165.86 contract is for the delivery of 4,567,229,402 units of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a period of performance through March 3, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the...